We are delighted to announce the appointment of three new members to our advisory board, who join us as we expand our business and product offering.
Nick Walls, Lee Harrison, and Raymond Sze bring a wealth of experience to Ecoinomy in the fields of SaaS technologies, cryptocurrencies, and brand, operations, and business marketing. The appointments are part of a strategic recruitment program that will enable Ecoinomy to expand its services and continue the development of our innovative seed-to-sale blockchain technology that will facilitate affordable access to organic medicines.
|



NICK WALLS
Nick Walls is ex-CEO and founder of r2cOnline, a leading global provider of cloud-based software to the commercial fleet sector, which he exited in 2019 to Fleetcor Inc, a Fortune 250 company. Nick is an experienced SaaS investor, often also acting as a mentor and Board Advisor to early-stage companies.
RAYMOND SZE
Raymond Sze is a seasoned online gaming and marketing executive with extensive experience in the Asian, European, and African markets, for companies such as Bitcoin.com and 138.com. He cofounded KamPay—a digital platform for Africa with bases in Nigeria and Cameroon whose goal it is to help promote financial inclusion throughout the continent.
Lee Harrison is the CEO and founder of Spark Emotions, a global consumer psychology agency, and ex-Brand/Marketing Director at Tescos. He has over 20 years of experience in business strategy, operation, and marketing strategy through to execution specialising in retail, FMCG, and media.
Steve McGeough Joins Ecoinomy as Head of Transformation
We are happy to announce that Steve McGeough has joined the Ecoinomy team to lead us through an integral stage of transformation.
Steve has extensive experience and a successful track record as a Business Leader & Transformation Director with leading FTSE businesses and global FMCG brands, with the last 10 years at executive committee level. At Tesco Mobile Steve was accountable for annual sales of £bn+, operating budgets of £multi-million+, 500 stores, and 2500 colleagues. Steve has a strong commercial focus with in-depth understanding of business drivers and data-led customer insights, and can effectively identify transformational opportunities and champion new digital and technology solutions to deliver seamlessly world-class brand experiences.
In his most recent role, he led the successful Direct To Consumer (DTC) transformation at Vuse; British American Tobacco’s vaping business creating a digital first omnichannel shopping experience.
In addition, Steve is Vice Chair for Honeycroft a charity that specialises in providing affordable child care.
We are delighted to welcome Steve to the Ecoinomy team as we continue to transform and grow. Steve comes with a wealth of experience, and a proven track record in business performance, and will be instrumental in taking our company forward. We look forward to working with him
We are delighted to welcome Steve to the Ecoinomy team as we continue to transform and grow. Steve comes with a wealth of experience, and a proven track record in business performance, and will be instrumental in taking our company forward. We look forward to working with him

We think you might also like this posts:


Crypto Adoption: Is It Steadily Moving Towards the Mainstream?
The world of cryptocurrency is still in its early days, and there is ample opportunity for wider adoption and growth. While Bitcoin has been around for over a decade now, estimates show crypto adoption rates are still in the single


Tokenomics 101: An Introduction to the Economics of Cryptocurrencies for Medicinal Cannabis Companies
With legalisation spreading across the globe, more and more medical cannabis companies are looking for efficient ways to raise funds, manage supply chains, and reach customers without facing financial restrictions.
Enter, blockchain technology.
If you’re a medical cannabis company, then this article is for you. … Read More


Big Pharma vs. Organic Medicine: The Changing Landscape of Healthcare
The healthcare industry is undergoing a major shift as patients and practitioners increasingly recognise the value of organic medicines over synthetic pharmaceuticals. This change represents a power struggle between Big Pharma companies and the organic medicine movement. … Read More